IceCure Medical
ICCM
12 hedge funds and large institutions have $120K invested in IceCure Medical in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 9 closing their positions.
0.01% less ownership
Funds ownership: 0.02% → 0.01% (-0.01%)
29% less funds holding
Funds holding: 17 → 12 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
62% less capital invested
Capital invested by funds: $319K → $120K (-$198K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$33.3K |
| 2 |
KFG
Kingdom Financial Group
Peoria,
Arizona
|
+$19.8K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$10.4K |
| 4 |
MG
Mather Group
Chicago,
Illinois
|
+$2.07K |
| 5 |
BCWM
Bartlett & Co Wealth Management
Cincinnati,
Ohio
|
+$312 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$54.7K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$34.5K |
| 3 |
HF
HRT Financial
New York
|
-$24.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$22.3K |
| 5 |
VF
Virtu Financial
New York
|
-$21K |
ICCM Hedge Fund Activity: Q1 2024 in Review
12 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q1 2024, worth a combined $120K — down 62% from $319K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ICCM and 4 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $33.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $54.7K sold.
- 12 institutional investors held IceCure Medical (ICCM) as of Q1 2024, down from 17 in Q4 2023.
- Funds reported $120K of IceCure Medical stock for Q1 2024, down 62% quarter-over-quarter.
- 4 funds opened new IceCure Medical positions in Q1 2024 and 9 closed out, a net change of -5 holders.
- The largest IceCure Medical buyer in Q1 2024 was Geode Capital Management, an estimated $33.3K added.
- The largest IceCure Medical seller in Q1 2024 was Citadel Advisors, an estimated $54.7K sold.
Based on aggregated 13F filings for Q1 2024.